Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Japanese Journal of Clinical Oncology|November 5, 2021
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapyKazuhito Yamamoto, Atsushi Shinagawa, Courtney D DiNardo, et al.
Transplantation and Cellular Therapy|May 28, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient ageKosuke Takano, Masaharu Tamaki, Yoshitaka Inoue, et al.
American Journal of Hematology|May 1, 2025
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of RuxolitinibKazuki Sakatoku, Hirohisa Nakamae, Makoto Murata, et al.
Annals of Hematology|April 14, 2026
Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantationNoriyoshi Yoshinaga, Makoto Iwasaki, Koji Kato, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Myeloid Malignancies Over 70 Years Old: A Retrospective Analysis of the Japanese Nationwide RegistrySumiko Kobayashi, Hidehiro Itonaga, Shuhei Kurosawa, et al.
American Journal of Hematology|November 20, 2024
Different impacts of granulocyte colony-stimulating factor administration on allogeneic hematopoietic cell transplant outcomes for adult acute myeloid leukemia according to graft typeTakaaki Konuma, Kazuaki Kameda, Kaoru Morita, et al.
American Journal of Hematology|October 29, 2025
Platelet Recovery and Its Impact on Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Nationwide Retrospective StudyNaoki Kurita, Kazushi Maruo, Fumihiko Kimura, et al.
Blood Advances|January 4, 2020
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11Yuichi Ishikawa, Naomi Kawashima, Yoshiko Atsuta, et al.
Blood Advances|July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGICYu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Haematologica|June 25, 2026
Gradient of CD79B expression in diffuse large B-cell lymphoma corresponds to stages of germinal center B-cell differentiationYusuke Naoi, Ryota Chijimatsu, Tomohiro Urata, et al.
Pageof 13